 MORRISVILLE, N.C., Nov. 24, 2020 GLOBE NEWSWIRE -- Syneos Health, Inc. Nasdaq: SYNH the Company or Syneos Health, the only fully integrated biopharmaceutical solutions organization combining a CRO Contract Research Organization and a CCO Contract Commercial Organization, today announced the completion of the previously announced offering of 600.0 million aggregate principal amount of 3.625 senior notes due 2029 the Notes. The Notes are guaranteed, jointly and severally, on a senior unsecured basis, by certain of the Companys subsidiaries. 